REGN
REGN
NASDAQ · Biotechnology

Regeneron Pharmaceuticals

S&P 500 Nasdaq 100 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks Best Dividend Stocks
$714.89
+5.79 (+0.82%)
As of May 10, 9:32 PM ET ·
Analyst Consensus
Strong Buy
38
Analysts
Very High
Coverage
Buy 30 79%
Hold 8 21%
Sell 0 0%
Price Target
Analyst Price Target -89.3% upside
Low Target $61.79
Average Target $76.80
High Target $111.17
Current Price $714.89
Current
$714.89
Target
$76.80
$61.79 $76.80 avg $111.17
Scenario Analysis
Bear Case
$61.79
-91.4%
Low target
Base Case
$76.80
-89.3%
Avg target
Bull Case
$111.17
+-84.4%
High target
Risk/Reward
0.9x
Unfavorable
Price in Context
52-Week High
$821.11
-12.9% from high
52-Week Low
$476.49
+50.0% from low
50-Day SMA
$763.91
-6.4% vs SMA
200-Day SMA
$631.14
+13.3% vs SMA
RSI (14)
59.8
Neutral
Target vs 52W High
$76.80
-90.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%